

Bilateral penetrating corneal transplantation in a patient with keratoconus and Stormorken Syndrome: a clinical case
https://doi.org/10.33791/2222-4408-2024-3-165-172
Abstract
Introduction. Keratoconus is a progressive corneal disease that results in thinning, curvature change, and refractive alterations, significantly impairing. visual acuity, even to the point of light perception. In advance stages, corneal transplantation may be necessary. Purpose. This publication aims to analyze a clinical case of corneal transplantation in a patient with keratoconus and Stormorken Syndrome, a rare genetic disorder caused by mutations in the STIM1 gene leading to calcium channelopathies. Case description. Patient Z., a 24-year-old male diagnosed with Stormorken Syndrome in childhood, was referred to the Moscow City Ophthalmological Centre. Comprehensive evaluations, including biomicroscopy, keratopachimetry, and ultrasound eye examination, confirmed keratoconus in both eyes. The patient underwent bilaterial penetrating keratoplasty due to disease progression. Postoperatively, visual acuity was 0.8 in the right eye, and 0.7 in the left eye. Additional clinical observations including bilateral myositis (resistant to medication), hypoinflammation, thrombocytopenia, dyslexia, and proximal muscles weakness, of the consistent with Stormorken Syndrome. Genetical testing confirmed a pathogenic STMI1 mutation. Conclusion. Despite the high volume of keratoplasty procedures at our clinic, this case is noteworthy. The currrent literature lacks reports on penetrating keratoplasty using native donor material in patients with Stormorken Syndrome, highlighting the uniqueness of this case.
Keywords
About the Authors
G. Sh. ArzhimatovaRussian Federation
Gulzhiyan S. Arzhimatova - Cand. Sci. (Med.), Associate Professor at the Department of Ophthalmology of the Russian Medical Academy of Postgraduate Education; Head of the Moscow City Ophthalmological Center (MCOC).
5, 2nd Botkin Ave., Moscow, 125284; 2/1, Barrikadnaya Str., Moscow, 125993
Yu. B. Slonimsky
Russian Federation
Yuri B. Slonimsky - Dr.Sci.(Med.), Professor at the Department of Ophthalmology of the Russian Medical Academy of Postgraduate Education.
5, 2nd Botkin Ave., Moscow, 125284; 2/1, Barrikadnaya Str., Moscow, 125993
E. A. Salikhov
Russian Federation
Eldar A.Salikhov - Cand.Sci.(Med.),Head of the Ophthalmology Department No. 60 of the Moscow City Ophthalmological Center (MCOC).
5, 2nd Botkin Ave., Moscow, 125284
M. Yu. Shemyakin
Russian Federation
Matvey Yu. Shemyakin - Ophthalmologist at the Ophthalmology Department No. 64 of the Moscow City Ophthalmological Center (MCOC).
5, 2nd Botkin Ave., Moscow, 125284
A. I. Ibraimov
Russian Federation
Alim I. Ibraimov - Ophthalmologist at the Ophthalmology Department No. 60 of the Moscow City Ophthalmological Center (MCOC).
5, 2nd Botkin Ave., Moscow, 125284
References
1. Morin G, Bruechle NO, Singh AR, et al. Gain-of-function mutation in STIM1 (P.R304W) is associated with Stormorken syndrome. Hum Mutat. 2014;35(10):1221–1232. doi: 10.1002/humu.22621
2. Misceo D, Holmgren A, Louch WE, et al. A dominant STIM1 mutation causes Stormorken syndrome. Hum Mutat. 2014;35(5):556–564. doi: 10.1002/humu.22544
3. Stormorken H. Stormorkens syndrom [Stormorken’s syndrome]. Tidsskr Nor Laegeforen. 2002;122(30):2853–2856. (In Norwegian.)
4. Gamage TH, Gunnes G, Lee RH, et al. STIM1 R304W causes muscle degeneration and impaired platelet activation in mice. Cell Calcium. 2018;76:87–100. doi: 10.1016/j.ceca.2018.10.001
5. Böhm J, Chevessier F, Maues de Paula A, et al. Constitutive activation of the calcium sensor STIM1 causes tubular-aggregate myopathy. Am J Hum Genet. 2013;92(2):271–278. doi: 10.1016/j.ajhg.2012.12.007
6. Li A, Kang X, Edelman F, Waclawik AJ. Stormorken syndrome: A rare cause of myopathy with tubular aggregates and dystrophic features. J Child Neurol. 2019;34(6):321–324. doi: 10.1177/0883073819829389
7. Borsani O, Piga D, Costa S, et al. Stormorken syndrome caused by a p.R304W STIM1 mutation: The first italian patient and a review of the literature. Front Neurol. 2018;9:859. doi: 10.3389/fneur.2018.00859
8. Gamage TH, Gunnes G, Lee RH, et al. STIM1 R304W causes muscle degeneration and impaired platelet activation in mice. Cell Calcium. 2018;76:87–100. doi: 10.1016/j.ceca.2018.10.001
9. Fahrner M, Stadlbauer M, Muik M, et al. A dual mechanism promotes switching of the Stormorken STIM1 R304W mutant into the activated state. Nat Commun. 2018;9(1):825. doi: 10.1038/s41467-018-03062-w
10. Zheng L, Stathopulos PB, Li GY, Ikura M. Biophysical characterization of the EF-hand and SAM domain containing Ca2+ sensory region of STIM1 and STIM2. Biochem Biophys Res Commun. 2008;369(1):240–246. doi: 10.1016/j.bbrc.2007.12.129
11. Böhm J, Laporte J. Gain-of-function mutations in STIM1 and ORAI1 causing tubular aggregate myopathy and Stormorken syndrome. Cell Calcium. 2018;76:1–9. doi: 10.1016/j.ceca.2018.07.008
12. Mas Tur V, MacGregor C, Jayaswal R, et al. A review of keratoconus: Diagnosis, pathophysiology, and genetics. Surv Ophthalmol. 2017;62(6):770–783. doi: 10.1016/j.survophthal.2017.06.009
13. Rabinowitz YS. Keratoconus. Surv Ophthalmol.1998;42(4):297–319. doi: 10.1016/s0039-6257(97)00119-7
14. Hashemi H, Shaygan N, Asgari S, et al. ClearKone-Synergeyes or rigid gas-permeable contact lens in keratoconic patients: a clinical decision. Eye Contact Lens. 2014;40(2):95–98. doi: 10.1097/ICL.0000000000000016
15. Labiris G, Giarmoukakis A, Sideroudi H, et al. Impact of keratoconus, cross-linking and cross-linking combined with photorefractive keratectomy on self-reported quality of life. Cornea. 2012;31(7):734–739. doi: 10.1097/ICO.0b013e31823cbe85
Review
For citations:
Arzhimatova G.Sh., Slonimsky Yu.B., Salikhov E.A., Shemyakin M.Yu., Ibraimov A.I. Bilateral penetrating corneal transplantation in a patient with keratoconus and Stormorken Syndrome: a clinical case. The EYE GLAZ. 2024;26(3):165-172. (In Russ.) https://doi.org/10.33791/2222-4408-2024-3-165-172